DSCYX
Price
$30.43
Change
-$0.58 (-1.87%)
Updated
Jun 13 closing price
Net Assets
216.87M
FTHFX
Price
$44.42
Change
+$0.05 (+0.11%)
Updated
Jun 12 closing price
Net Assets
10.1B
Interact to see
Advertisement

DSCYX vs FTHFX

Header iconDSCYX vs FTHFX Comparison
Open Charts DSCYX vs FTHFXBanner chart's image
BNY Mellon Opportunistic Small Cap Y
Price$30.43
Change-$0.58 (-1.87%)
VolumeN/A
Net Assets216.87M
FullerThaler Behavioral Sm-Cp Eq R6
Price$44.42
Change+$0.05 (+0.11%)
VolumeN/A
Net Assets10.1B
DSCYX vs FTHFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DSCYX vs. FTHFX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSCYX is a Buy and FTHFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTHFX has more cash in the bank: 10.1B vs. DSCYX (217M). FTHFX (0.79) and DSCYX (0.78) have matching dividends . DSCYX was incepted earlier than FTHFX: DSCYX (9 years) vs FTHFX (14 years). DSCYX (0.86) is less costly to investors than FTHFX (0.63). DSCYX is a more actively managed with annual turnover of: 61.03 vs. FTHFX (41.00). DSCYX has a lower initial minimum investment than FTHFX: DSCYX (0) vs FTHFX (1000000). DSCYX annual gain was more profitable for investors over the last year : 3.51 vs. FTHFX (-0.80). FTHFX return over 5 years is better than : 96.39 vs. DSCYX (33.31).
DSCYXFTHFXDSCYX / FTHFX
Total Expense Ratio0.760.63121%
Annual Report Gross Expense Ratio0.860.63137%
Fund Existence9 years14 years-
Gain YTD-0.513-2.31222%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets217M10.1B2%
Annual Yield % from dividends0.780.7999%
Returns for 1 year3.51-0.80-436%
Returns for 3 years8.8141.9921%
Returns for 5 years33.3196.3935%
Returns for 10 yearsN/A137.11-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCUS9.24-0.11
-1.18%
Arcus Biosciences
NNBR1.93-0.03
-1.53%
NN
ALGN177.85-3.84
-2.11%
Align Technology
GMS76.03-1.77
-2.28%
GMS
OVID0.28-0.01
-3.15%
Ovid Therapeutics